1,596
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Effectiveness and safety of upadacitinib in patients with face and neck atopic dermatitis unresponsive to dupilumab

, , , , , , , & show all
Article: 2242540 | Received 21 Jul 2023, Accepted 22 Jul 2023, Published online: 01 Aug 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.